Wasawat Vutthikraivit, MD
Interventional Cardiology · St George, UTNPI 1588186456
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.8%), food and beverage and grants — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 42.3% of the total.
Across 55 payments — averaging $160.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$3K
- Inari Medical, Inc.$1K
- Shockwave Medical, Inc$223
- Medtronic$164
- Sanofi-aventis U.S. LLC$113
- plus $574 from 9 others
What the payments were for
- Grants$1,42116%
- Travel & lodging$4,13247%
- Food & beverage$3,06835%
- Education$2122%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $3,737 |
| Abbott | 19 | $2,811 |
| Inari Medical, Inc. | 6 | $1,211 |
| Shockwave Medical, Inc | 1 | $223 |
| Medtronic | 1 | $164 |
| Sanofi-aventis U.S. LLC | 1 | $113 |
| Penumbra, Inc. | 2 | $111 |
| Cordis US CORP. | 1 | $102 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $89 |
| Cathworks, Inc. | 1 | $84 |
| Chiesi USA, Inc. | 1 | $72 |
| Abiomed | 2 | $40 |
| Novo Nordisk | 1 | $32 |
| Biotronik Inc. | 2 | $28 |
| Getinge USA Sales, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,832 in reported general payments places this provider in the 65th percentile of 45 interventional cardiology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 54 | $602 |
| Spironolactone | 14 | $215 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in St George
- Blake GardnerSt George$267K
- Jared CrisafiSt George$24K
- Alberto BrizolaraSt George$7K
- Olusola LajaSt George$3K
- David BoormanSt George$3K
- Mark PulsipherSt George$391
- Vamsee YagantiSalt Lake City$390K
- Anwar TandarSalt Lake City$131K
- Sanjeev TrehanOgden$95K
- Stavros DrakosSalt Lake City$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.